MIV Therapeutics develops a wide range of medical devices for cardiovascular treatments, including the first Polymer-Free Sirolimus Eluting Stent. They have a world-class manufacturing plant in Gujarat, India and offer OEM services for stent cutting. The company delivers its innovative products to physicians through a direct domestic sales force and international distributor network. MIV Therapeutics is committed to research and development, clinical excellence, and global expansion, with a particular interest in Latin America and the CIS region.